IL16 and chronic obstructive pulmonary disease: Using the public LGRC data repository, we found that the expression profiles of IL16, STARD5, and ME3 in human lung samples showed statistically significant differences (P < 0.05) between COPD patients and controls (Figure S3 in File S1).